SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-027029
Filing Date
2019-11-08
Accepted
2019-11-08 19:14:29
Documents
2
Period of Report
2019-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7794
2 EX-24 DOCUMENT attachment1.htm EX-24 3966
  Complete submission text file 0000899243-19-027029.txt   13129
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Issuer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address
Naschitz Anat (Reporting) CIK: 0001792060 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39122 | Film No.: 191205339